23 May 2013
Keywords: canada, oks, merck, maxalt, health, approved, co
Article | 16 September 1999
Health Canada has approved Merck & Co's Maxalt (rizatriptan) forthe treatment of migraine. The product will be available in a tablet ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 September 1999
17 September 1999
15 September 1999
© 2013 thepharmaletter.com